Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 418064, 3 pages
http://dx.doi.org/10.1155/2014/418064
Editorial

Plant-Made Biologics

1The Biodesign Institute, Arizona State University, 1001 S. McAllister Avenue, Tempe, AZ 85287, USA
2School of Life Sciences, Arizona State University, 1001 S. McAllister Avenue, Tempe, AZ 85287, USA
3Department of Science and Technology for Agriculture, Forestry, Nature and Energy (DAFNE), University of Tuscia, Via San Camillo de Lellis snc, 01100 Viterbo, Italy
4Department of Biological Systems Engineering, Virginia Tech, Blacksburg, Virginia, VA 24061, USA

Received 18 May 2014; Accepted 18 May 2014; Published 2 June 2014

Copyright © 2014 Qiang Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Q. Chen, “Expression and manufacture of pharmaceutical proteins in genetically engineered horticultural plants,” in Transgenic Horticultural Crops: Challenges and Opportunities—Essays by Experts, B. Mou and R. Scorza, Eds., pp. 83–124, Taylor & Francis, Boca Raton, Fla, USA, 2011. View at Google Scholar
  2. D. Bosch, A. Castilho, A. Loos, A. Schots, and H. Steinkellner, “N-glycosylation of plant-produced recombinant proteins,” Current Pharmaceutical Design, vol. 19, no. 31, pp. 5503–5512, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Lico, Q. Chen, and L. Santi, “Viral vectors for production of recombinant proteins in plants,” Journal of Cellular Physiology, vol. 216, no. 2, pp. 366–377, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Lai and Q. Chen, “Bioprocessing of plant-derived virus-like particles of Norwalk virus capsid protein under current good manufacture practice regulations,” Plant Cell Reports, vol. 31, no. 3, pp. 573–584, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. M.-A. D'Aoust, M. M.-J. Couture, N. Charland et al., “The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza,” Plant Biotechnology Journal, vol. 8, no. 5, pp. 607–619, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. J. He, H. Lai, M. Engle et al., “Generation and analysis of novel plant-derived antibody-based therapeutic molecules against West Nile virus,” PLoS ONE, vol. 9, no. 3, Article ID e93541, 2014. View at Publisher · View at Google Scholar
  7. Q. Chen and H. Lai, “Plant-derived virus-like particles as vaccines,” Human Vaccines and Immunotherapeutics, vol. 9, no. 1, pp. 26–49, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Traynor, “Taliglucerase alfa approved for Gaucher disease,” American Journal of Health-System Pharmacy, vol. 69, no. 12, p. 1009, 2012. View at Publisher · View at Google Scholar · View at Scopus